Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a dismal disorder, but conversion surgery (CS) has provided possibilities of better prognosis for unresectable (UR-)PDAC. We retrospectively investigated the clinical benefits of CS in patients with UR-PDAC. We performed CS in 20 of the 398...

Descripción completa

Detalles Bibliográficos
Autores principales: Mataki, Yuko, Kurahara, Hiroshi, Idichi, Tetsuya, Tanoue, Kiyonori, Hozaka, Yuto, Kawasaki, Yota, Iino, Satoshi, Maemura, Kosei, Shinchi, Hiroyuki, Ohtsuka, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958855/
https://www.ncbi.nlm.nih.gov/pubmed/33801465
http://dx.doi.org/10.3390/cancers13051057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958855/
https://www.ncbi.nlm.nih.gov/pubmed/33801465
http://dx.doi.org/10.3390/cancers13051057

Ejemplares similares